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Tumor Enhancers: Underestimated
Factors in the Epidemiology of Lifestyle
Associated Cancers
by Ernst L. Wynder*
Model studies in carcinogenesis give ample evidence of synergistic, tumor-promoting and cocarci-
nogenic effects of environmental agents and dietary factors in regard to the induction and propaga-
tion of neoplasms. This presentation examines tumor enhancers deriving from the use of tobacco
and alcohol as well as the effects of dietary fat and other food components on endocrinological and
gastrointestinal factors that contribute to tumor development in the breast and colon.
It is suggested that epidemiologic surveys need to intensify investigations on the interrelation-
ship of tumor enhancers and genotoxic agents in high risk populations and that they need to study
especially the dose-response effects ofsuch agents.
Experimental studies should focus increasingly on epidemiologic leads that suggest potential en-
hancers of genotoxic agents and should delineate mechanisms involved in such multistep carcino-
genesis processes. This approach would be a prerequisite forchemoprevention.
Recommendations for changes of lifestyle habits and practical approaches towards reduction of
tumor enhancers in consumer goods and in the environment are additional requirements for appro-
priate preventive strategies.
Introduction
The history of recorded environmental cancer be-
gins in the 18th century, in an era which Shimkin
calls "the age of reason" (1). In 1761, John Hill of
London published his "Cautions Against the Immod-
erate Use of Snuff," when he associated this form of
tobacco use with the occurrence of nasal polyps and
cancers. In 1775, Percival Pott observed the correla-
tion of exposure to soot with the frequent incidence
of scrotal cancer in chimney sweeps. These early no-
tations have been followed by many other clinical
observations relating environmental factors to in-
creased incidences of various forms of neoplasms
and bringing into being the field of environmental
cancer epidemiology and environmental carcinogen-
esis (1, 2). In each case, observations of the human
conditions were eventually followed by attempts to
uncover the specific carcinogens that might be re-
sponsible for the effects in man. However, experi-
mental oncology had, of necessity, to be limited to
testing of candidate carcinogens in laboratory ani-
mals. These model studies have given us an insight
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into the mechanisms by which chemicals induce neo-
plasms. Be;enblum and Shubik documented in the
1940s that the effects of a carcinogen could.be pro-
moted by subsequent application of a noncarcinogen
(3-5) and further research with model experiments
in animals has taught us the distinction between tu-
mor promotion and cocarcinogenesis (the result of
long-term coapplication ofa carcinogen and a noncar-
cinogen) (6, 7). In addition, secondary factors, such as
changes in enzyme chemistry or in the organization
of cell membranes or immunological insufficiencies
effect increases oftumor yield (8).
For the purpose of this review we shall group all
agents other than initiators and carcinogens and all
conditions that increase tumor yields under the cat-
egory of "tumor enhancers," although we realize
that the term "enhancement" denotes something de-
sirable and that increased tumor yield is certainly
undesirable except for the purposes of studying
mechanisms in laboratory models. Tumor enhancers
differ from tumor initiators or carcinogens in two
important aspects: (1) their action is reversible and
they function as nongenotoxic agents (8). Their ef-
fectiveness usually depends on long-term exposure
and on a large total dose. This has important mecha-
nistic as well as practical implications because theE. L. WYNDER
dose response and the extrapolation in regard to a
threshold level for these agents are different from
those for genotoxins (9).
These considerations are of central importance to
the cancer epidemiologist because the effects of "tu-
mor enhancers" might only be seen at relatively
high and constant dosage. Cessation of the exposure
to enhancers is followed by a steep decline in tumor
yield, quite in contrast to terminating the applica-
tion of a carcinogen, which has little effect on the ul-
timate tumor yield.
In fact, the preventive oncologist needs to learn
to distinguish the initiators, carcinogens and tumor
enhancers in human risk assessment, if we are to
look for more successful approaches towards re-
ducing cancer risks (10, 11). The experimentalist and
epidemiologist need to join forces in studying "tu-
mor enhancers" that affect humans because as Ber-
enblum stated "The ultimate aim of the study of ex-
perimental carcinogenesis is the prevention of can-
cer in man" (5). While studies on croton oil and its
active constituents are of obvious academic interest,
the mechanism of action of such compounds may
have little or no counterpart in man. However, man
is exposed to a variety of tumor enhancers or inhibi-
tors working in unison to stimulate or prevent the
development of an initiated cell.
The following are examples from cancer epidemi-
ology that should be of equal concern to both epi-
demiologist and experimental oncologist.
Tobacco
It is clear from extensive experimental studies by
our group and others that the complete carcinogen-
ic effect of smoke condensate on the epidermis of
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FIGURE 1. Decline oflung cancer risk in ex-smokers.
be due solely to identified or potentially present
complete carcinogens (12-14). Experimental studies
have, in fact, shown a tumor-promoting effect for
the weakly acidic portion of the smoke and a cocar-
cinogenic effect for catechol, as well as for various
neutral smoke constituents (12-14). The speed of de-
cline in the rate of lung cancer of ex-smokers sug-
gests a response to the withdrawal of tumor en-
hancers (Fig. 1) (15). An increased lung cancer rate
was observed in the first 3 years after cessation of
smoking. This is believed to be due to the fact that
many who have smoked excessively, give up the
habit because of severe chronic bronchitis while, in
fact, the incipient cancer is already present. The de-
cline in lung cancer risk, which eventually becomes
apparent after an individual changes from nonfil-
ter- to filter-cigarettes with a lower tar yield,
might be due, in part, to a reduction in tumor en-
hancers which is concomitant with reduction of tar
exposure (15-17). However, it might also relate to
the selective reduction of weakly acidic components
by smoke filtration and it might reflect the reduced
exposure to tumor initiators in the smoke of low-
yield cigarettes as a dose response effect. Smokers
frequently counteract reduction of total particulate
matter and nicotine in smoke by increasing ciga-
rette consumption or inhaling more intensely in or-
der to maintain a desired physiological nicotine
level. Nevertheless, the reduction of total smoke
particulates is likely to be of benefit in regard to re-
ducing risks for those tobacco-related cancers that
are associated with direct contact with the smoke.
Alcohol
Alcohol is a classic tumor enhancer (18, 19). It has
no effect in low doses (less than two drinks per day),
and it appears to have no essential effect by itself.
Tobacco acts as the initiator, and alcohol abuse (all
types ofalcohol) acts as a tumor enhancer at least in
regard to effects on the oral cavity, larynx (glottic
and supraglottic) and esophagus (Fig. 2). The lung is
not affected nor is the pancreas. The fact that the
vocal cord is affected suggests that direct contact of
the tissues with alcohol is not a necessary factor.
We have been interested in the mechanisms where-
by alcohol increases a smoker's risk for cancer of
the upper alimentary tract, in part, because of our
studies on the association of Plummer-Vinson dis-
ease and cancer of the upper alimentary tract in
women (20, 21). Could the related roles of iron and
riboflavin in cellular oxidation represent a common
ground? Certainly, in mice riboflavin deficiency pro-
duces atrophy, hyperkeratosis, and hyperplasia of
epidermal tissue, and gross abnormalities in mito-
chondria (20).
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In our studies we have made the following obser-
vations (23-26). Enzyme activity is measureable for
squamous cells of the hamster cheek pouch, al-
though at a somewhat lower rate than in liver cells
of the hamster. Upon consuming 35% of caloric in-
take in the form of ethanol, the microsomal enzyme
activity in liver cells of hamsters increases. We
must assume, although we have not measured this,
that such increase also takes place in the squamous
cells of the cheek pouch of hamsters. Increased en-
zyme activity in the liver cells leads to an increase
in a-hydroxylation, the presumed activation mecha-
nism of the carcinogenic nitrosopyrrolidine. It re-
mains to be shown whether the changes in enzyme
activity may render detoxification processes ofpoly-
nuclear aromatic hydrocarbons less efficient, or
whether there is activation in sensitive tissues. In
vivo experiments show an increased yield in tumors
of the nasal cavity and trachea in chronic ethanol-
consuming hamsters treated with nitrosopyrrolidine
but not in those treated with nitrosonornicotine (26).
A question remains as to whether the lower risk
of beer drinkers, particularly those in countries
where beer has a high vitamin B content, is due to a
lower alcohol content of the beer, a dilution by high
fluid intake, or a protective influence of the B vita-
mins, and especially of riboflavin. Should alcohol be
fortified with riboflavin? Should excessive drinkers
be encouraged to consume vitamin B supplements?
Should we focus on more detailed studies of the nu-
RELATIVE RISKS OF LARYNX CANCER BY DAILY
CONSUMPTION OF ALCOHOL AND CIGARETTES
FOR MALES ( p<0.05). not significant
tritional deficiencies which are likely to occur in in-
dividuals whose caloric intake includes an excessive
amount of alcohol? This represents a challenge to
the preventive oncologist, to the epidemiologist,
and to the biochemist.
Nutrition
Dietary Fat Affecting Endocrinological
Factors Related to Breast Cancer
In the rat, both estrogen and prolactin appear to
be necessary factors for breast tumor growth and
development, although they are not carcinogenic in
themselves (27). In humans, breast cancer is signifi-
cantly less common if castration has occurred be-
fore a woman reaches the late thirties (28). The risk
for breast cancer is increased if menopause occurs
late. In Japan, breast cancer incidence is particu-
larly low in the postmenopausal group of patients.
The rate of breast cancer increases in Japanese mi-
grants to Hawaii but mainly in the second genera-
tion, suggesting that tumor initiation starts early in
life and occurs less commonly in Japanese women
than in women in the Western world (29). Breast
cancer is now increasing in Japan (30). The one fac-
tor that can best account for these epidemiological
observations is nutrition, particularly dietary fat
content (31, 32).
Tannenbaum (33) showed more than three de-
RELATIVE RISKS OF ORAL CAVITY CANCER BY DAILY
CONSUMPTION OF ALCOHOL AND CIGARETTES FOR
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FIGURE 2. Relative risks of (left) larynx cancer and (right) oral cavity cancer by daily consumption of alcohol and cigarettes for
males (p < 0.05). An asterisk (*) indicates values not significant.
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FIGURE 3. Effects of dietary fat.
cades ago that dietary fat increases the growth of
spontaneous mammary tumors. These studies have
been confirmed and extended by Carroll (34) and by
our own group (35) using carcinogen-induced mam-
mary tumor systems (Fig. 3). In these experiments,
both saturated and unsaturated fats act as tumor
enhancers. In the rat model, dietary fat has been
shown to override the inhibiting effect on tumor de-
velopment produced by removing the ovaries (36)
and to increase the secretion of the tumor-pro-
moting hormone prolactin, during proestrus (27).
Hill (37) has shown that diet profoundly affects pro-
lactin levels in women and that women who are on
a Western diet experience reduced menstrual flow
as well as a reduction of the number of days of the
cycle when placed on a vegetarian diet (38). Possible
pathways by which dietary fat may exert its pro-
moting effects on mammary tumor development
have been discussed and reviewed by several inves-
tigators (35, 36, 39).
The effects of dietary components may not be ap-
parent when measuring hormones in the serum but
may be distinguished by determining hormone lev-
els in breast secretion. We have reported on the es-
trogen and prolactin content of breast aspirates of
Finnish women who were free of breast disease (40).
We noted a twofold increase in prolactin and a six-
fold increase in estrogen in breast fluid as compared
to serum concentrations. In ongoing studies with
American and Japanese women, we observe the
largest difference to occur with respect to the
amount of free cholesterol in ductal aspirates, which
is more than two times higher in the Western
women.
As much as 60% of nipple aspirates contain exfo-
liated mammary parenchymal cells many of which
stain heavily for lipids. Hence it may be that at
least part of the hormonal cell lipid content of ductal
fluid is contributed by exfoliated cells. The quantita-
tive and qualitative aspects of breast fluid cytology
in populations of differing risk for breast cancer re-
mains to be explored. We believe that the cellular
content of breast fluids may reflect the integrity of
the ductal epithelium of the breast in Western and
Japanese women which, in turn, may reflect the rel-
ative differences in breast cancer risk.
We may hypothesize that the lipid nature of the
breast fluid and/or the lipid content of mammary
cell membranes might determine the interaction of
water-soluble prolactin and fat-soluble estrogens
with their respective receptors. The interaction of
hormones is, of course, complicated, and it is likely
that we will advance preventive strategies long be-
fore we understand the interactions of hormones
such as estrogens, prolactin, or intracellular regula-
tors such as prostaglandins in tumor enhancement.
Clearly, the metabolic epidemiologist can play a
role. More attention must be given to the biochem-
istry of breast secretion. Diet in terms of total satu-
rated and unsaturated fat would appear to act as a
modifier by affecting the hormonal milieu within
the breast, a milieu that, in turn, affects carcinogen-
esis. It remains to be shown whether cholesterol
epoxides, documented to be present in breast secre-
tion, may play a role as tumor initiators as sug-
gested by Petrakis et al. (41).
In terms of breast cancer epidemiology, we also
need to consider that dietary fat may influence the
survival of postmenopausal patients with breast
cancer, a subject not part of this presentation.
Dietary Fat and Other Food Components
Affecting Colon Cancer
Epidemiologic and animal studies suggest that
diet is a major etiologic factor in colon cancer (27,
42). Diets high in total fat and low in fiber are asso-
ciated with an increased incidence of colon cancer in
man. High dietary fiber acts as a protective factor
in populations consuming a high amount of total fat
(43, 44).
The modifying effects of dietary factors in colon
carcinogenesis are summarized in Table 1. With re-
gard to the concept of dietary factors and colon can-
cer, Aries et al. (45) have suggested that the amount
of dietary fat determines the levels of intestinal bile
acids as well as the composition of the gut micro-
flora, and that the gut microflora metabolizes these
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Table 1. Modifying factors in colon cancer.
Dietary fata Dietary fibersa,b Micronutrients
Increases bile acid Certain fibers increase Include vitamins, minerals,
secretion into gut fecal bulk and dilute antioxidants, etc.
carcinogens and promoters
Increases metabolic Modify metabolic activity Modify carcinogenesis at
activity of gut of gut bacteria activation and
bacteria detoxification level
Increases secondary Modify the metabolism Act also at promotional





aDietary factors, particularly high totaldietary fat and a relative lack ofcertain dietary fibers and vegetables have a role.
bHigh dietary fiber of fibrous foods may be a protective factor even in the high dietary fat intake.
acid sterols to tumorigenic compounds active in the
colon. Reddy et al. (46, 47) suggested that the di-
etary fat increases the excretion ofbile acids intothe
gut, as well as modifies the activity of gut micro-
flora which enhances the formation of secondary
bile acids in the colon. These secondary bile acids
act as tumor promoters in the colon (46, 47).
The mechanism ofaction of bile acids in colon car-
cinogenesis has not been elucidated. Bile acids have
been shown to affect cell kinetics and proliferation
in the intestinal epithelium (47). Lipkin (48) demon-
strated that during neoplastic transformation of co-
lonic cells, a similar sequence of changes leading to
uncontrolled proliferative activity develops in colon
cancer in humans and in rodents given a colon car-
cinogen. Recent studies suggest that the induction
of colonic epithelial ornithine decarboxylase (ODC)
activity by the bile acids may play a role in these
mechanisms (49). Obviously, further studies are war-
ranted on the mechanism of tumor-enhancing activ-
ity of various bile acids.
The possible mechanism of a protective effect of
dietary fiber against colon cancer has been the sub-
ject of a recent workshop (50). The protective effect
of dietary fiber may be due to adsorption, dilution
or metabolism of cocarcinogens, promoters and yet-
to-be-identified carcinogens by the components of
the fiber (51-53). Different types of nonnutritive fi-
bers possess specific binding properties. Dietary fi-
ber could also affect the enterohepatic circulation of
bile salts (54). Fiber not only influences bile acid me-
tabolism, thereby reducing the formation of tumor
enhancers in the colon, but also exerts a solventlike
effect, in that it dilutes potential carcinogens and co-
carcinogens by its bulking effect and is able to bind
bile acids and certain carcinogenic compounds
(53-57).
Recently, there has been considerable interest in
the identification of inhibitors of carcinogenesis that
may have value in the prevention of colon cancer. A
substantial number of compounds occurring natu-
rally and synthetic substances have been shown to
inhibit colon carcinogenesis (58). An example of
these compounds are naturally occurring indoles,
antioxidants, and micronutrients such as indole-3-
carbinol, indole-3-acetonitrile, vitamins A, C, and E
and selenium and synthetic antioxidants, namely bu-
tylated hydroxyanisole (BHA) and the butylated hy-
droxytoluene (BHT).
The suggestion that promotion may be involved
in intestinal cancer has been supported by the ob-
servation that the carcinogenic response to a vari-
ety of intestinal carcinogens is enhanced by the die-
tary fat which in itself is not carcinogenic. Recent
studies indicate that the enhanced tumorigenesis in
the animals fed the high-fat diet is due to tumor pro-
moting effects (59). Ingestion of high-fat diet in-
creased the intestinal tumor incidence when it fol-
lows azoxymethane (AOM) (carcinogen) administra-
tion, but not when it occurs during or before AOM
treatment. The carcinogenic process in the human
may have similar characteristics since there is a
good correlation between the findings in a variety
of animal studies and those in humans. The fact that
ubiquitous environmental carcinogens are present
at very low concentrations suggests that tumor en-
hancing factors may have a preponderant influence
on the eventual outcome of the neoplastic process in
humans. Due to the variety of initiating agents and
the possible difficulties in removing them from the
environment, the promotional phase of carcinogene-
sis may be a more promising area for development
ofpreventive measures.
Summary
Epidemiological studies, supported by experimen-
tal data, demonstrate that a variety of nongenotoxic
factors enhance the development of cancer in man
by potentiating or promoting the effect of carcino-20 E. L. WYNDER
gens. These variables affect a preponderance of hu-
man cancers. Our recommendations are as follows.
(1) To the epidemiologist we recommend that he
pinpoint further the interaction of tumor enhancers
and genotoxic agents and, in particular, study the
differences in dose-response effects of these agents.
Epidemiological studies of high and low risk pop-
ulations and detailed investigations of outliers can
contribute much to an understanding of the en-
hancement of carcinogenesis by environmental and
lifestyle factors.
(2) To the experimentalist we suggest that he fol-
low the epidemiologist's leads and study the mecha-
nisms whereby certain suspected nongenotoxic
agents potentiate carcinogenesis. Greater under-
standing of these mechanisms might permit the
introduction of chemotherapeutic and chemopreven-
tive approaches to tumor enhancers which is likely
to be quite specific for a given class of tumor en-
hancers. The study of tumor enhancers known to af-
fect carcinogenesis in man can be just as exciting,
fruitful and, in the long run, more rewarding in re-
ducing human cancer risk than the study of highly
active promoters in model experiments which do
not or only remotely relate to man's exposure.
(3) To the preventive oncologist we recommend
that he counsel the individual as to lifestyle-habits
and advise manufacturers and the regulatory agen-
cies how to reduce exposure to tumor enhancers of
products and environments. Since tumor enhancers
are not genotoxic, since their action is reversible,
and since they generally act at relatively high
doses, it is likely that when the final chapter on en-
vironmental carcinogenesis is written, our greatest
success may well have been the result of our ability
to reduce tumor enhancers. Such reduction is most
likely to occur through the appropriate interaction
of all the varied disciplines now involved in envi-
ronmental cancer research.
Our studies are made possible through the Core Support of
our research facilities by Grant No. CA 17613 from the Na-
tional Cancer Institute.
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